Overview
News
Technologies
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$63.8M
1 round on record
Latest round
$63.8M
Venture round · Dec 2021 · 4 yr ago
Team
51-200
employees, estimated range
Hiring now
1
+1 posted in 30 days
Backers
3
Canaan, Nextech Invest
The money's age
Long since its last round
57 months since the last round · and hiring
Momentum
28/100
hiring for its size, in the news
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Dec 31, 2021 Raised a round Venture round $63.8M · SEC Form D 2021 Founded
Funding rounds
RoundDateAmountInvestorsSource
Venture round Dec 2021 $63.8M — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity Alterome Therapeutics, Inc. SEC Form D
Founders and leadersfrom filings, registers and the company's site
Eric MurphyExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Avenzo TherapeuticsSeries B $60M · 12 mo ago • Founded 2022 • 201-500 employees • 4 roles
Avenzo Therapeutics is a clinical-stage biotechnology company that develops next-generation targeted oncology therapies. It was co-founded…
NormunitySeries B $75M · 21 mo ago • Founded 2020 • 201-500 employees
We create medicines that free normal immunity to defeat cancer using proprietary platforms that uncover novel immuno-oncology mechanisms.
Accent is pioneering a new class of small molecule precision cancer therapies that target critical intracellular dependencies that span…
SirnaMed TherapeuticsConvertible Note $1.3M · 2 yr ago • Founded 2023 • 51-200 employees
SirnaMed is committed to developing innovative therapies that directly target the cause of cancer development, progression and treatment…
Leucid BioVenture round · 19 mo ago • Founded 2014
CAR T therapies with more durable responses, improving treatment outcomes and saving the lives of patients with refractory cancers.
BrainChild BioSeries A $116M · 1 mo ago • 51-200 employees • 3 roles
BrainChild Bio is a kids-first, clinical-stage biotechnology company harnessing the power of CAR-T cell technology for tumors in the…

Overview

Alterome is a clinical-stage precision oncology company developing first-in-class, alteration-specific therapies for AKT E17K- and KRAS-driven cancers.

News

News Pulse 2.0 1 month ago
Alterome Therapeutics Names Former Poseida CFO Johanna Mylet As Chief Financial Officer
Alterome Therapeutics has appointed Johanna Mylet, CPA, Chief Financial Officer as the clinical-stage precision oncology company advances its pipeline of KRAS-targeting cancer therapies.
Read more
Report
Blog 1 month ago
Alterome Therapeutics Appoints Johanna Mylet as Chief Financial Officer
Former Poseida Therapeutics CFO joins Alterome Therapeutics as the company prepares to accelerate development of KRAS-targeting medicines The post Alterome Therapeutics Appoints Johanna Mylet as Chief Financial Officer appeared first on Alterome.
Read more
Report
News YahooFinance 1 month ago
Alterome Therapeutics Appoints Johanna Mylet as Chief Financial Officer
SAN DIEGO, September 08, 2026--Alterome Therapeutics, Inc., a clinical-stage biopharmaceutical company pioneering the development of next-generation therapies targeting oncogenic driver mutations for the treatment of cancer, today announced the appointmen
Read more
Report
Blog 7 months ago
Alterome Therapeutics to Participate in Upcoming Investor Conferences
The post Alterome Therapeutics to Participate in Upcoming Investor Conferences appeared first on Alterome.
Read more
Report
Blog 8 months ago
Alterome Therapeutics Appoints Leo Faoro, MD, MBA, as Chief Medical Officer
Veteran medical oncologist with a proven track record of advancing cancer therapies from early trials through regulatory approval to lead ongoing clinical development of ALTA2618 and ALTA3263 The post Alterome Therapeutics Appoints Leo Faoro, MD, MBA, as
Read more
Report
News PRNewswire 8 months ago
PRN_FinancialWrapper
PRN_FinancialWrapper
Read more
Report
Show more news

Tech stack

Technologies named in job postings at Alterome over the last 12 months, by layer, with the share of postings for each.
Technologies in use
1
Postings analysed
1
Stack modernity
64/100
Cloud & platforms
GCP
Sign in to see how your skills match this stack Sign In

Salary insights

Compensation ranges based on this company's open jobs
Median
$250k
Typical range
$250k
Open positions
1
1 Jobs
Architect 100%
Level Jobs Median Typical range
Architect 1 $250k $250k
Highest paying role Associate Director, Clinical Operations $250k
Normalized to USD per year

People

Eric Murphy
Executive Officer, Director
Thilo Schroeder
Director
Ryan Corcoran
Director
Carl Gordon
Director
Arjun Goyal
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Growth

Hiring Momentum
28/100
Slowing
Open positions
1
0 opened / 0 closed in 30 days
ATS activity
Every ~3 hours
Today
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Early Careers
100% ▲

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
1
Countries
1
Busiest office
San Diego
San Diego United States
HQ
Corporate Office
1 open roles 1 posted in 90 days 50-200 est. staff $250k Avg Salary
hires for Early Careers
13480 Evening Creek Drive North, Suite 450, San Diego, CA 92128
seen since Sep 2026 careers board, company site, job postings

Financials

Total raised
$63.8M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
Round Announced Amount
Venture - Series Unknown 2021 $63.8M Details